This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Humacyte, Inc. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Geoffrey Erickson: Innovator in Soft Tissue Augmentation
Introduction
Geoffrey Erickson is a notable inventor based in Westport, CT (US). He has made significant contributions to the field of soft tissue augmentation through his innovative research and development. With a focus on human collagen and elastin, his work has the potential to impact various medical applications.
Latest Patents
Geoffrey Erickson holds 1 patent for his invention titled "Compositions and methods for soft tissue augmentation." This patent provides compositions that comprise isolated human collagen, isolated human elastin, and a pharmaceutically acceptable carrier. Notably, the human elastin is substantially insoluble in water and has a molecular weight greater than 100 kDa. The invention also includes methods and kits designed for effective soft tissue augmentation.
Career Highlights
Erickson's career is marked by his role at Humacyte, Inc., where he has been instrumental in advancing tissue engineering technologies. His expertise in the field has allowed him to contribute to groundbreaking research that aims to improve patient outcomes in soft tissue repair and augmentation.
Collaborations
Throughout his career, Geoffrey has collaborated with esteemed colleagues, including Laura E. Niklason and Yuling Li. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of medical research.
Conclusion
Geoffrey Erickson's contributions to soft tissue augmentation through his patented inventions and collaborative efforts highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile